Artiva Biotherapeutics (ARTV) Non Operating Income (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported Non Operating Income of $2000.0 for Q1 2026, down 99.89% year-over-year from $1.9 million in Q1 2025, and up 200.0% quarter-over-quarter from -$2000.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Non Operating Income (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Non Operating Income data on file, last reported at $2000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at $2000.0, down 99.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 4.23% YoY), and the FY2025 annual result was -$14000.0, down 108.92% from the prior year.
- Non Operating Income rose to $2000.0 in Q1 2026 per ARTV's latest filing, from -$2000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $2.0 million in Q4 2023 and troughed at -$1.7 million in Q2 2024.
- A 4-year average of $516166.7 and a median of $444000.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income sank 406.11% in 2024, then surged 1165.31% in 2025.
- A 4-year view of Non Operating Income shows it stood at $2.0 million in 2023, then slumped by 78.96% to $420000.0 in 2024, then sank by 100.48% to -$2000.0 in 2025, then jumped by 200.0% to $2000.0 in 2026.
- Business Quant data shows ARTV's Non Operating Income at $2000.0 in Q1 2026, -$2000.0 in Q4 2025, and -$3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 420,000.00 |
| Sep 30, 2024 | 863,000.00 |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | 147,000.00 |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 468,000.00 |
| Jun 30, 2023 | 540,000.00 |